C-Rad AB (publ) (CRAD-B.ST) — Stock Score Summary

C-Rad AB (publ) (CRAD-B.ST) has a MoatMap StockRank of 76/100 based on Quality (69/100), Value (25/100), and Momentum (64/100) factor scores. The current signal is BUY.

Key Financial Metrics

Price$3.85
Market Cap$91M
P/E (TTM)40.34
P/E (Forward)15.71
Price/Book3.46
Return on Equity8.8%
Return on Invested Capital4.7%
Debt/Equity2.70
Gross Margin73.9%
Operating Margin11.5%
Revenue Growth-11.9%
Dividend Yield0.3%
Free Cash Flow$-41K

C-Rad AB (publ) operates in the Medical Devices industry, part of the Healthcare sector (Sweden).

Frequently Asked Questions

What is C-Rad AB (publ)’s (CRAD-B.ST) StockRank?
MoatMap’s StockRank for C-Rad AB (publ) (CRAD-B.ST) is 76/100, with a Buy signal. It is a composite of Quality (69), Value (25), and Momentum (64) factor ranks across MoatMap’s 15,000+ stock universe.
Does C-Rad AB (publ) have an economic moat?
C-Rad AB (publ) (CRAD-B.ST) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is C-Rad AB (publ) a buy, hold, or sell?
MoatMap’s current signal for C-Rad AB (publ) (CRAD-B.ST) is Buy, based on a StockRank of 76/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is C-Rad AB (publ) in?
C-Rad AB (publ) (CRAD-B.ST) operates in the Healthcare sector, specifically the Medical Devices industry (Sweden).
Browse all ranked stocksCRAD-B.ST deep dive reportAI ChampionsHow we score stocksSense-check another stock